Latest

Learn how antibiotic-resistant UTI testing identifies ESBL, CRE, resistance genes, and antibiotic susceptibility, and how culture results guide treatment and follow-up.

Antibiotic-Resistant UTI Test: ESBL, CRE, Resistance Markers, and Culture Meaning

Learn what asymptomatic bacteriuria means, how a positive urine culture without UTI symptoms is interpreted, and when screening, treatment, or follow-up matters.

Asymptomatic Bacteriuria Test: Positive Culture Without Symptoms and When It Matters

Learn how bacteria in urine are interpreted using urinalysis, culture, colony count, symptoms, and sample quality, including when contamination or follow-up testing matters.

Bacteria in Urine Test: UTI, Contamination, Colony Count, and Culture Follow-Up

Learn how a catheter urine culture helps diagnose catheter-associated UTI, how samples are collected, and what colony counts, pyuria, resistance, and positive results mean.

Catheter Urine Culture Test: Catheter-Associated UTI and Culture Meaning

Learn how a chlamydia and gonorrhea urine NAAT works, how to collect first-catch urine, what positive or negative results mean, and when follow-up testing is needed.

Chlamydia and Gonorrhea Urine NAAT Test: STI Screening, Positive Result, and Meaning

Learn how to collect a clean-catch urine culture, reduce contamination, handle the sample correctly, and understand mixed flora, colony counts, repeat testing, and accurate results.

Clean-Catch Urine Culture Test: Sample Collection, Contamination, and Accurate Results

Diagnostics

Home Diagnostics Page 15

Understand the Xpert Bladder Cancer Monitor urine test, its five mRNA gene markers, positive and negative result meaning, recurrence accuracy, and role alongside cystoscopy.

Xpert Bladder Cancer Monitor Test: Urine Gene Markers, Recurrence Monitoring, and...

Learn what an ALK IHC test detects, how ALK positivity is interpreted in lung cancer and lymphoma, and when FISH or NGS is used to confirm an ALK fusion.

ALK IHC Test: ALK Protein Expression, Lung Cancer, Lymphoma, and Fusion...

Learn how the arginase-1 IHC test supports hepatocellular carcinoma, what positive staining means, and how it helps distinguish liver origin from metastatic tumors.

Arginase-1 IHC Test: Liver Cancer Marker, Hepatocellular Differentiation, and Tumor Origin

Learn what BCL2 IHC positivity means in follicular lymphoma and DLBCL, how BCL2 relates to MYC, and why protein expression is different from a gene rearrangement.

BCL2 IHC Test: Lymphoma Marker, Positive Staining, and Prognosis Meaning

Learn what BCL6 IHC positive staining means, how BCL6 identifies germinal-center patterns in lymphoma, and why BCL6 protein expression differs from gene rearrangement.

BCL6 IHC Test: Lymphoma Marker, Germinal Center Pattern, and Positive Staining

Learn what calretinin IHC positive staining means, how it supports mesothelioma and mesothelial origin, and why BAP1, MTAP, and carcinoma markers are often needed.

Calretinin IHC Test: Mesothelioma Marker, Tumor Origin, and Positive Staining

Learn what CD3 IHC positive staining means, how CD3 supports T-cell lineage, and why reactive T cells, antigen loss, and NK/T-cell lymphoma can complicate interpretation.

CD3 IHC Test: T-Cell Lymphoma Marker, T-Cell Lineage, and Positive Staining

Learn what a positive CD10 IHC result means in follicular lymphoma and other lymphomas, how germinal center staining is interpreted, and why companion tests matter.

CD10 IHC Test: Follicular Lymphoma, Germinal Center Marker, and Positive Staining

Learn how CD15 IHC is used in classic Hodgkin lymphoma, what positive and negative staining mean, and how CD30, PAX5, CD20, and other markers guide classification.

CD15 IHC Test: Hodgkin Lymphoma Marker, Positive Staining, and Tumor Classification

Learn what CD20-positive IHC staining means, how it supports B-cell lymphoma lineage, why some B-cell tumors are CD20 negative, and how CD20 can relate to targeted therapy.

CD20 IHC Test: B-Cell Lymphoma Marker, B-Cell Lineage, and Positive Staining

Understand what a CD30 IHC test shows, how positive staining is interpreted in Hodgkin lymphoma and T-cell lymphoma, and why CD30 results require a full pathology panel.

CD30 IHC Test: Hodgkin Lymphoma, T-Cell Lymphoma, and Positive Staining

Learn what CD34 IHC positivity means in bone marrow, leukemia, vascular tumors, and soft-tissue tumors, including staining patterns, pitfalls, and follow-up tests.

CD34 IHC Test: Leukemia, Vascular Tumors, Stem Cell Marker, and Positive...

Understand CD45 (leukocyte common antigen) IHC, what positive or negative staining means, how it helps identify lymphoma, and why marker panels are essential.

CD45 IHC Test: Leukocyte Common Antigen, Lymphoma Marker, and Tumor Origin

Learn what CD56 IHC positivity means in neuroendocrine tumors and NK-cell neoplasms, including staining patterns, marker panels, diagnostic pitfalls, and next steps.

CD56 IHC Test: Neuroendocrine Tumor, NK Cell Tumor, and Positive Staining

Understand what CD117 (c-KIT) IHC positivity means in GIST, mast cell disorders, leukemia, and other tumors, including staining patterns and follow-up tests.

CD117 (c-KIT) IHC Test: GIST, Mast Cell Tumors, Positive Staining, and...

Understand CDX2 IHC positivity in colorectal and GI cancers, including nuclear staining, metastatic tumor-origin panels, CDX2-negative colorectal cancer, and key pitfalls.

CDX2 IHC Test: Colorectal Cancer Marker, GI Tumor Origin, and Positive...

1...141516...137 Page 15 of 137